logo
episode-header-image
Aug 7
36m 31s

EP 199: Functional genomics at scale: Us...

Sano Genetics
About this episode

This week on The Genetics Podcast, Patrick is joined by Xin Jin, Associate Professor in the Department of Neuroscience at The Scripps Research Institute. They discuss how in vivo Perturb-seq enables scalable and high-resolution modeling of neurogenetic disorders like autism, how introducing mutations directly into living mouse brains reveals cell-type vulnerabilities and convergent pathways, and why this approach could transform therapeutic development by identifying shared mechanisms across diverse genetic mutations.


Show Notes: 

0:00 Intro to The Genetics Podcast

00:58 Welcome to Xin 

01:52 Overview of in vivo Perturb-seq

05:10 Identifying de novo variants in autism spectrum disorder

09:00 Using perturbations to map how autism-linked mutations affect specific brain cell types

13:04 Applying Perturb-seq to other brain diseases

14:30 In vivo versus in vitro models and extending genetic screening approaches beyond the brain

18:44 Using in vivo models to trace variant effects, rank gene drivers, and uncover therapeutic pathways

22:35 Conservation of genes between mouse and human in the context of neurodevelopmental disease modeling 

24:21 Impact of genetic discoveries on drug development by convergence onto common pathways 

27:22 Xin’s early interest in science through her grandfather’s work in plant taxonomy and botany

29:48 Xin’s path from China to MIT and how early research shaped her scientific mindset

31:58 Reflections on AI’s rapid progress and limits in biology, and the need for new models 

37:21 Closing remarks


Find out more

Please consider rating and reviewing us on your chosen podcast listening platform! 

https://drive.google.com/file/d/1Bp2_wVNSzntTs_zuoizU8bX1dvao4jfj/view?usp=share_link

Up next
Today
EP 208: Gene therapy at a crossroads: Successes, concerns, and the path forward
Summary: This week on The Genetics Podcast, Patrick Short takes a solo deep dive into the current state of gene therapy ahead of next week’s live recording at ASHG. He explores the promise and limitations of adeno-associated virus (AAV) delivery, examples of gene therapies for ne ... Show More
42m 58s
Oct 2
EP 207: Decoding Parkinson’s genetics on a global scale with Andy Singleton and Sonya Dumanis of GP2 and ASAP
Summary: This week on The Genetics Podcast, Patrick is joined by Andy Singleton, Program Lead of the Global Parkinson’s Genetics Program (GP2), and Sonya Dumanis, COO of the Coalition for Aligning Science. They discuss the creation of GP2, how the initiative is closing representa ... Show More
43m 51s
Sep 25
EP 206: From caregiving to catalyzing FTD research with Wanda Smith of CureGRN
This week on The Genetics Podcast, Patrick is joined by Wanda Smith, founder of CureGRN. They discuss Wanda’s journey from caring for her mother to driving FTD research, the discovery of progranulin and development of new therapies, the diagnostic odyssey and need for earlier gen ... Show More
38m 34s
Recommended Episodes
Apr 2024
PT500 – Shulgin Farm and the Future of Psychedelic Drug Development, with Paul F. Daley, Ph.D.
In this episode, Joe interviews Paul F. Daley, Ph.D., who worked with Sasha Shulgin in his lab for the last seven years of his life, helping him finish (and co-authoring) "The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds." He is now the co-founder, ... Show More
36m 1s
Sep 15
Faster Science, Better Drugs
Can we make science as fast as software? In this episode, Erik Torenberg talks with Patrick Hsu (cofounder of Arc Institute) and a16z general partner Jorge Conde about Arc’s “virtual cells” moonshot, which uses foundation models to simulate biology and guide experiments. They dis ... Show More
56m 26s
Mar 2025
The Science, Evolution, and Future of Lifespan and Healthspan with Dr. Michael Ringel
On this episode of Longevity by Design, Dr. Gil Blander speaks with Dr. Michael Ringel, COO of Life Biosciences, about the science of aging and longevity. Michael discusses how evolution influences lifespan and why aging occurs. He explains the trade-off between resource allocati ... Show More
1h 12m
Jan 2025
Rachel Chevalier - Update on Topical Steroids for EoE
In this episode, hosts Drs. Temara Hajjat and Jenn Lee talk to Dr. Rachel Chevalier. Dr. Chevalier is a pediatric gastroenterologist and physician scientist at Children's Mecy Hospital. She is an Associate Professor at the University of Missouri-Kansas City School of Medicin ... Show More
54m 42s
Jul 2024
Exploring Pain Science with Paul Ingraham: From Massage Therapy to Scientific Writing
In this episode, we welcome Paul, a former massage therapist turned scientific writer, who shares his journey from clinical practice to founding the PainScience.com website. Paul discusses the evolution of his career, the challenges of transitioning to science writing, and the im ... Show More
52m 6s
Feb 2025
Leading Stem Cell Expert: Stem Cells 101 - The Future of Medicine w/ Robert Hariri | EP #147
In this episode, Bob and Peter discuss Stem Cells 101, why it’s not available in America, and the importance of stem cell treatment for humanity.  Recorded on Nov 21st, 2024Views are my own thoughts; not Financial, Medical, or Legal Advice. Dr. Robert Hariri is the Chairman, Foun ... Show More
1h 18m
Feb 2025
AI Biohacking Breakthroughs: Transform Your Health with Gary Brecka's Top Strategies | EP #149
In this episode, Gary and Peter discuss the most important bio hacks people should know and cover a list of health tech gadgets they have at home and use daily to live longer.  Recorded on Jan 23rd, 2024Views are my own thoughts; not Financial, Medical, or Legal Advice. Gary Brec ... Show More
1h 37m
Sep 24
Episode 65. Circulating Tumor DNA in DLBCL with Dr. Ash Alizadeh and Dr. David Russler-Germain
In this episode of Blood Cancer Talks, hosts Eddie, Ashwin, and Raj welcome two distinguished experts to explore the cutting-edge field of circulating tumor DNA (ctDNA) in B-cell lymphomas. Dr. David Russler-Germain, a lymphoma clinician from Siteman Cancer Centre at Washington U ... Show More
53m 8s
Feb 2025
Understanding AI’s Expanding Role in Drug Discovery and Life Sciences R&D - Liran Belenzon of BenchSci
Today’s guest is Liran Belenzon, Co-founder and CEO of BenchSci. BenchSci is a global leader in AI solutions for preclinical R&D that helps decipher complex biomedical research using proprietary technology. Liran joins us to discuss how AI is transforming disease biology research ... Show More
19m 3s
Jan 2025
#333 ‒ Longevity roundtable — the science of aging, geroprotective molecules, lifestyle interventions, challenges in research, and more | Steven Austad, Matt Kaeberlein, Richard Miller
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter In this special episode of The Drive, Peter introduces a brand-new roundtable format. Joined by three renowned experts in longevity science—Steven A ... Show More
2h 41m